Article Text

PDF
Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns
  1. David Palmero1,2,
  2. Emilienne Chavan1,2,
  3. Markoulina Berger-Gryllaki1,
  4. Jean-François Tolsa3,
  5. Ermindo R Di Paolo1,
  6. André Pannatier1,2,
  7. Hugues Henry4,
  8. Farshid Sadeghipour1,2
  1. 1 Department of Pharmacy, Lausanne University Hospital, Lausanne, Switzerland
  2. 2 School of Pharmaceutical Sciences, Geneva and Lausanne Universities, Geneva, Switzerland
  3. 3 Clinic of Neonatology, Lausanne University Hospital, Lausanne, Switzerland
  4. 4 Department of Biomedicine, Lausanne University Hospital, Lausanne, Switzerland
  1. Correspondence to Dr David Palmero, Service de Pharmacie, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, CH1011 Lausanne, Switzerland; david.palmero{at}chuv.ch

Abstract

Objective We aimed to monitor the physicochemical stability of prostaglandin E1 (PGE1) 1.5 and 15 µg/mL in 10% dextrose stored in polypropylene syringes.

Methods We developed a liquid chromatography-high resolution mass spectrometry (LC-HRMS) method to detect and quantify levels of PGE1. Method selectivity was performed with a mixture of PGE1 and its degradation products. Forced degradation tests were performed to determine which degradation products were most likely to form. PGE1 injection solutions in 10% dextrose were stored in unprotected and shielded-from-light polypropylene syringes in a climatic chamber. Samples were taken immediately after preparation (T0) and after 24, 48, 72 and 168 hours for analysis. PGE1 solutions were considered stable if ≥90.0% of the initial concentration was retained.

Results The LC-HRMS method was validated in the range of 0.086–0.200 µg/mL PGE1 with trueness values between 98.2% and 100.3%, and repeatability and intermediate precision values of <2.2% and <4.7%, respectively. The quantification and detection limits of the method were 0.086 and 0.026 µg/mL, respectively. PGE1 and its degradation products were resolved chromatographically. PGE1 injection solutions were ≥90.0% stable after 48 hours in unprotected from light (UPL) syringes. The solutions remained clear without precipitation, colour or pH modification and subvisible particles within the permitted levels. Prostaglandin A1 was the sole degradation product observed.

Conclusions A LC-HRMS method to evaluate PGE1 stability in a 10% dextrose was developed and validated. PGE1 1.5 and 15 µg/mL in 10% dextrose solution are stable for 48 hours when stored at 30°C in UPL polypropylene syringes.

  • alprostadil
  • prostaglandins E
  • liquid chromatography
  • mass spectrometry
  • drug stability
  • newborn
  • intensive care unit
  • neonatal

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.